Links:
[1] http://www.imi.europa.eu/content/home
[2] http://www.imi.europa.eu/content/mission
[3] http://www.imi.europa.eu/content/history
[4] http://www.imi.europa.eu/content/objectives
[5] http://www.imi.europa.eu/content/expected-effects
[6] http://www.imi.europa.eu/content/research-agenda
[7] http://www.imi.europa.eu/content/governance
[8] http://www.imi.europa.eu/content/executive-office
[9] http://www.imi.europa.eu/content/executive-director
[10] http://www.imi.europa.eu/content/governing-board
[11] http://www.imi.europa.eu/content/scientific-committee
[12] http://www.imi.europa.eu/content/states-representatives-groups
[13] http://www.imi.europa.eu/content/candidate-and-associated-countries
[14] http://www.imi.europa.eu/content/jobs
[15] http://www.imi.europa.eu/content/procurement
[16] http://www.imi.europa.eu/content/budget-0
[17] http://www.imi.europa.eu/content/ongoing-projects
[18] http://www.imi.europa.eu/content/understanding-chronic-pain-and-improving-its-treatment
[19] http://www.imi.europa.eu/content/unbiased-biomarkers-prediction-respiratory-disease-outcomes
[20] http://www.imi.europa.eu/content/surrogate-markers-micro-and-macro-vascular-hard-endpoints-innovative-diabetes-tools-0
[21] http://www.imi.europa.eu/content/physical-activity-crucial-patient-reported-outcome-copd
[22] http://www.imi.europa.eu/content/pharmaceutical-medicine-training-programmes-0
[23] http://www.imi.europa.eu/content/pharmacoepidemiological-research-outcomes-therapeutics-european-consortium
[24] http://www.imi.europa.eu/content/integrating-bioinformatics-and-chemoinformatics-approaches-development-expert-systems-allo-0
[25] http://www.imi.europa.eu/content/novel-methods-leading-new-medications-depression-and-schizophrenia
[26] http://www.imi.europa.eu/content/improving-beta-cell-function-and-identification-diagnostic-biomarkers-treatment-monitoring-0
[27] http://www.imi.europa.eu/content/prediction-cognitive-properties-new-drug-candidates-neurodegenerative-diseases-early-clinica
[28] http://www.imi.europa.eu/content/european-programme-pharmacovigilance-and-pharmacoepidemiology
[29] http://www.imi.europa.eu/content/european-modular-education-and-training-programme-safety-sciences-medicines
[30] http://www.imi.europa.eu/content/biomarkers-and-molecular-tumour-classification-non-genotoxic-carcinogenesis-0
[31] http://www.imi.europa.eu/content/clinical-biomarker-qualification-safer-and-faster-evidence-based-translation-0
[32] http://www.imi.europa.eu/content/european-medicines-research-training-network
[33] http://www.imi.europa.eu/content/pilot-project-innomed
[34] http://www.imi.europa.eu/content/overview-imis-calls-how-participate
[35] http://www.imi.europa.eu/content/intellectual-property-policy
[36] http://www.imi.europa.eu/content/future-topics
[37] http://www.imi.europa.eu/content/new-opportunities
[38] http://www.imi.europa.eu/content/8th-call-2012
[39] http://www.imi.europa.eu/content/stage-1-6
[40] http://www.imi.europa.eu/content/7th-call-2012
[41] http://www.imi.europa.eu/content/stage-2-6
[42] http://www.imi.europa.eu/content/stage-1-5
[43] http://www.imi.europa.eu/content/6th-call-2012
[44] http://www.imi.europa.eu/content/5th-call-2012
[45] http://www.imi.europa.eu/content/4th-call-2011
[46] http://www.imi.europa.eu/content/3rd-call-2010
[47] http://www.imi.europa.eu/content/2nd-call-2009
[48] http://www.imi.europa.eu/content/1st-call-2008
[49] http://www.imi.europa.eu/content/subscribe-imi-newsletter
[50] http://www.imi.europa.eu/content/newsletter-archive
[51] http://www.imi.europa.eu/content/news-ticker
[52] http://www.imi.europa.eu/content/events
[53] http://www.imi.europa.eu/content/press-releases
[54] http://www.imi.europa.eu/content/media-coverage
[55] http://www.imi.europa.eu/content/scientific-publications
[56] http://www.imi.europa.eu/content/social-media
[57] http://www.imi.europa.eu/content/how-drug-developed
[58] http://www.imi.europa.eu/content/images-and-animations
[59] http://www.imi.europa.eu/content/info-material-and-publication
[60] http://www.imi.europa.eu/content/documents
[61] http://www.imi.europa.eu/content/faq
[62] http://www.imi.europa.eu/content/send-us-message
[63] http://www.imi.europa.eu/content/links
[64] http://imi.europa.eu/print/53
[65] http://imi.europa.eu/content/sitemap
[66] http://imi.europa.eu/content/legal-notice-0